Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

NPR

20 Jan 2020 0 shares 1 views

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

NPR

Published 20 Jan 2020

Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.

Full Article

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic

You might like